CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 701 enrolled
Drug / intervention
Intervention (INT1)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01741428
NCT01741428N/ACompleted

"Hjerteloeftet". Early Interventions to Promote Physical Activity, Dietary Lifestyle Changes and Optimal Medication for Cardiovascular Risk Factor Reduction in Over 3 Years Follow-up.

LHL Helse·interventional·Posted Dec 4, 2012·Updated Feb 28, 2020

In Brief

A clinical study evaluating Intervention (INT1) for Cardiovascular Disease. Completed, enrolled 701 participants across 1 site.

Detailed Summary

Early interventions to promote physical activity, dietary lifestyle changes and optimal medication for cardiovascular risk factor reduction - 3 years follow-up. A randomized Clinical Trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNorway
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 4, 2012
Enrollment StartNov 1, 2012
Primary CompletionFeb 6, 2019
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 13.6 years ago

Interventions

Intervention (INT1)behavioral

The course Program at the Feiring Heart Clinic will: Clinical examination and ergospirometric testing, optimizing both treatment and prophylactic medication. Promoting physical Activity, changes in lifestyle, dietary changes/weight reduction, smoking cessation. In the follow-up period the participants will be contacted and report regularly through a web-based secure program (MedAxess)(such as: Activity-, dietary- and smoking habits). Each participant will have their own Mentor, helping keeping up the motivation. They will also meet regularly at the local doctors Office which reports relevant parameters to the Project (such as weight, BP, Lipoproteins, blood glucose/HbA1C)